NCT06003777 A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults Status COMPLETED Phase PHASE1
NCT06003348 Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones Status RECRUITING Phase PHASE4
NCT06002152 Superficial Cervical Plexus Block and Quality of Recovery After Thyroidectomy Status COMPLETED Phase PHASE2
NCT06001177 A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease Status COMPLETED Phase PHASE2
NCT06000891 A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 Status TERMINATED Phase PHASE1
NCT06000410 A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee Status COMPLETED Phase PHASE3
NCT05999799 A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT05999708 A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants Status WITHDRAWN Phase PHASE1
NCT05999240 Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder Status RECRUITING Phase PHASE2
NCT05998837 GLUcose Transport and REnalPROtection in Chronic Kidney Disease Status COMPLETED Phase PHASE2/PHASE3
NCT05998759 Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia Status RECRUITING Phase PHASE2
NCT05998525 Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography Status COMPLETED Phase PHASE3
NCT05997641 Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05997576 A Study of TG103 Injection in Non-diabetic Overweight or Obesity Status COMPLETED Phase PHASE3
NCT05997277 Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). Status TERMINATED Phase PHASE2
NCT05995444 A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT05995392 The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease Status UNKNOWN Phase EARLY_PHASE1